Maintenance immunotherapy after autologous bone marrow transplantation (ABMT) in relapsed follicular (R-FL) and mantle cell (R-MC) lymphomas (NHL). A monoinstitutional experience

Maurizio Rupolo,Mariagrazia Michieli,Rosa Manuele,Michele Spina,Pietro Bulian,Massimo Degan,Mario Mazzucato,L. Abbruzzese,Umberto Tirelli

Maintenance immunotherapy after autologous bone marrow transplantation (ABMT) in relapsed follicular (R-FL) and mantle cell (R-MC) lymphomas (NHL). A monoinstitutional experience

2008

Maurizio Rupolo
Mariagrazia Michieli
Rosa Manuele
Michele Spina
Pietro Bulian
Massimo Degan
Mario Mazzucato
L. Abbruzzese
Umberto Tirelli

18012 Background: Recent evidences supported the benefit of Rituxan in combination with chemotherapy in CD20+ NHL. Further maintenance therapy with Rituxan resulted in improved event free survival ...

Keywords:

Follicular phase
Pathology
Cell
Oncology
Bone marrow
Transplantation
Immunotherapy
Medicine
Internal medicine
autologous bone
marrow transplantation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations